![Seppo Salminen profile picture](/sites/default/files/styles/profile_picture_horizontal/public/images/profile/672646.jpg?itok=r3u2-czN)
Seppo
Salminen
Senior Advisor, Nutrition and Food Research Center (NuFo)
MSc, MS, PhD
Links
Areas of expertise
Professor, Director
gut microbiota, probiotics and prebiotics, nutrition and food safety, EU regulations
Teaching
Functional Foods and EU legislation, Lactic acid biotechnology
Research
Food and health, intestinal microbiota, probiotics, prebiotics, functional foods, food legislation, health claims, novel foods
Publications
Scientific Opinion on the substantiation of health claims related to water and maintenance of normal physical and cognitive functions (ID 1102, 1209, 1294, 1331), maintenance of normal thermoregulation (ID 1208) and “basic requirement of all living things” (ID 1207) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of health claims related to the raw fruit of Emblica officinalis Gaertn. and maintenance of normal blood LDL-cholesterol concentrations (ID 4041) and protection of DNA, proteins and lipids from oxidative damage (ID 4042) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of a health claim related to isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) and maintenance of normal blood pressure pursuant to Article 13(5) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of health claims related to sodium and maintenance of normal muscle function (ID 359) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Scientific Opinion on the substantiation of health claims related to mycoprotein and maintenance of normal blood LDL-cholesterol concentrations (ID 1619) and increase in satiety leading to a reduction in energy intake (ID 1620) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))Evaluation of the ability of Bifidobacterium longum to metabolize human intestinal mucus (2011)
FEMS Microbiology Letters
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))